Oinonen Lasse, Tikkakoski Antti, Koskela Jenni, Eräranta Arttu, Kähönen Mika, Niemelä Onni, Mustonen Jukka, Pörsti Ilkka
Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Department of Clinical Physiology, Tampere University Hospital, Tampere, Finland.
Endocr Connect. 2021 Jan;10(1):54-65. doi: 10.1530/EC-20-0446.
Parathyroid hormone has been related with the risk of hypertension, but the matter remains controversial. We examined the association of parathyroid hormone with central blood pressure and its determinants in 622 normotensive or never-treated hypertensive subjects aged 19-72 years without diabetes, cardiovascular or renal disease, or cardiovascular medications. The methods were whole-body impedance cardiography and analyses of pulse wave and heart rate variability. Cardiovascular function was examined in sex-specific tertiles of plasma parathyroid hormone (mean concentrations 3.0, 4.3 and 6.5 pmol/L, respectively) during head-up tilt. Explanatory factors for haemodynamics were further investigated using linear regression analyses. Mean age was 45.0 (s.d. 11.7) years, BMI 26.8 (4.4) kg/m2, seated office blood pressure 141/90 (21/12) mmHg, and 309 subjects (49.7%) were male. Only five participants had elevated plasma parathyroid hormone and calcium concentrations. Highest tertile of parathyroid hormone presented with higher supine and upright aortic diastolic blood pressure (P < 0.01) and augmentation index (P < 0.01), and higher upright systemic vascular resistance (P < 0.05) than the lowest tertile. The tertiles did not present with differences in pulse wave velocity, cardiac output, or measures of heart rate variability. In linear regression analyses, parathyroid hormone was an independent explanatory factor for aortic systolic (P = 0.005) and diastolic (P = 0.002) blood pressure, augmentation index (P = 0.002), and systemic vascular resistance (P = 0.031). To conclude, parathyroid hormone was directly related to central blood pressure, wave reflection, and systemic vascular resistance in subjects without cardiovascular comorbidities and medications. Thus, parathyroid hormone may play a role in the pathophysiology of primary hypertension.
甲状旁腺激素与高血压风险相关,但此事仍存在争议。我们在622名年龄在19至72岁之间、无糖尿病、心血管或肾脏疾病且未服用心血管药物的血压正常或未经治疗的高血压受试者中,研究了甲状旁腺激素与中心血压及其决定因素之间的关联。研究方法包括全身阻抗心动图以及脉搏波和心率变异性分析。在头高位倾斜期间,对血浆甲状旁腺激素按性别分为三分位数(平均浓度分别为3.0、4.3和6.5 pmol/L)进行心血管功能检查。使用线性回归分析进一步研究血流动力学的解释因素。平均年龄为45.0(标准差11.7)岁,体重指数为26.8(4.4)kg/m²,坐位办公室血压为141/90(21/12)mmHg,309名受试者(49.7%)为男性。只有5名参与者的血浆甲状旁腺激素和钙浓度升高。与最低三分位数相比,甲状旁腺激素最高三分位数的仰卧位和直立位主动脉舒张压(P<0.01)和增强指数(P<0.01)更高,直立位全身血管阻力更高(P<0.05)。三分位数在脉搏波速度、心输出量或心率变异性测量方面没有差异。在线性回归分析中,甲状旁腺激素是主动脉收缩压(P = 0.005)和舒张压(P = 0.002)、增强指数(P = 0.002)和全身血管阻力(P = 0.031)的独立解释因素。总之,在没有心血管合并症和未服用药物的受试者中,甲状旁腺激素与中心血压、波反射和全身血管阻力直接相关。因此,甲状旁腺激素可能在原发性高血压的病理生理学中起作用。